Informed patients choose: surgery or not for torn ACL?

NCT ID NCT05585528

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explored whether giving detailed information to people with a torn anterior cruciate ligament (ACL) in the knee changes their decision to have surgery or try non-surgical treatment. About 106 adults with a recent ACL tear were included. The main goal was to see how many chose surgery within 45 days after receiving clear information about both options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

106 people

The number who actually took part.

Started

Dec 2022

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Rupture, partial or complete, of the anterior cruciate ligament less than 3 months old (confirmed by magnetic resonance imaging); * Patient with no contraindication to surgery or functional management, according to the medical team; * Patient able to understand the information related to the study, to read the information leaflet and having consented to participate in the study * Patient benefiting from a social security scheme; Exclusion Criteria: * Grade 3 associated ligament injury on the fibular collateral ligament and/or the tibial collateral ligament; * Symptomatic meniscal lesion; * Practice of sport in national or international competition ; * Recurrence of rupture of the same anterior cruciate ligament; * Patient with a neurological (motor and/or sensory), vestibular or rheumatic pathology; * Pregnant woman ; * Protected adult patient (under guardianship, or under a regime of deprivation of liberty).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ligament rupture are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinique de la Sauvegarde

    Lyon, 69009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.